🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT04189172
Active, not recruiting Observational

MiDura-Study (Neuro-Patch in Duraplasty)

NCT04189172 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2020-02-06
Last updated
2026-03-18

Condition(s) studied

MeningiomaTumor, BrainChiari MalformationVascular MalformationHydrocephalusTethered CordDural FistulaCraniotomySpinal SurgeryDuraplasty

Study summary

The aim of this study is to collect systematically and proactively data regarding the performance of Neuro-Patch, like complications and handling, under daily clinical practice when used as intended by the manufacturer

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Written informed consent * Age \> 18 years * Duraplasty using Neuro-Patch® according to the Instructions for Use Exclusion Criteria: * Use in infected regions * Use in open cerebrocranial traumata * Use in open spina bifida * Known hypersensitivity to implant materials * Pregnancy * Representation by a legal guardian or under involuntary commitment

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
Service de Neurochirurgie, Hôpital de la Cavale Blanche Brest France
Hopital Pierre Wertheimer - HCL Bron France
Klinik für Neurochirurgie, Universitätsklinikum des Saarlandes Homburg/Saar Germany
Krankenhaus Ludmillenstift Meppen Germany

More Aesculap AG trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04189172 on ClinicalTrials.gov ↗ ← All trials in Germany